7.23.20 | HPV
Identifying Barriers to Prevention, Screening, and Treatment of HPV and Related Cancers
At an SWHR roundtable, experts and patients identified gaps in research, clinical practice, policy, and education related to HPV-associated diseases.
7.16.20
SWHR Announces Dr. Shontelle Dodson as Board Chair
SWHR is pleased to announce the election of Shontelle Dodson, PharmD, as the new Chair of its Board of Directors.
7.14.20 | Policy
SWHR Applauds House Appropriations Committee for Advancing HHS Funding Increases
In the midst of the COVID-19 pandemic, the work of U.S. public health agencies is more important than ever. SWHR commends the House Appropriations Committee on its approval of a FY21 appropriations bill increasing funding for NIH to $47 billion.
6.30.20 | Policy
Women and Value Assessment: Striving to Capture the Patient Experience
SWHR hosted three value assessment experts at its recent policy meeting to discuss the integration of women’s health priorities into assessments of new health care innovations.
6.22.20 | HPV
Women with Anal Cancer: ‘The Invisible Victims of HPV’
Anal cancer is a rare and incredibly stigmatized disease — and the majority of cases in the U.S. occur in women.
6.5.20
SWHR Stands With the Black Community Against Racial Injustice
The Society for Women’s Health Research stands with the Black community against racial injustice.
6.1.20 | Mental Health
Pandemic Prompts Concerns About Worsening Mental Health for Pregnant Women and New Moms
In the midst of COVID-19, pregnant women and new moms are being forced to confront unexpected challenges and possible worst-case scenarios about delivery and the postpartum period.
5.29.20 | Policy
ICER’s Value Framework: A Work in Progress for Women’s Health
ICER's updated value assessment framework embraces several of SWHR’s recommendations, but more work remains to adequately evaluate the value of health care interventions for women.
5.28.20 | Policy
New Screening and Diagnostic Technologies Could Pave the Way for Improvements in Women’s Health
Some of screening and diagnostic tests for women are woefully outdated or nonexistent, resulting in uncertainties about their disease risk and difficulty with diagnosis.
